Revolutionising Fashion with Microbially-Derived Materials
Modern Synthesis, a pioneering biotechnology company, has successfully closed a $5.5 million funding round to accelerate the commercialisation of its innovative biomaterial technology. The highly sought-after funding round was spearheaded by Extantia Capital, with backing from Artesian and Collaborative Fund. This investment will enable the company to expand production capacity at its pilot facility and meet the growing demand from leading fashion brands.
With sustainability at the forefront of the fashion industry, brands are under increasing pressure to adopt environmentally friendly materials. Studies indicate that by 2030, the fashion sector will face a 133 million tonne shortfall of low-impact raw materials. Modern Synthesis offers a cutting-edge solution by developing biobased materials that align with the industry’s decarbonisation goals while providing superior performance.
Innovative Materials for a Sustainable Future
Modern Synthesis’ proprietary process transforms nanocellulose a natural fibre derived from fermentation into durable, high-quality alternatives to animal leather, synthetic ‘vegan’ leather, and plastic-coated textiles. Unlike traditional materials, which often rely on petrochemicals and toxic additives, Modern Synthesis’ biomaterial is free from harmful ingredients while maintaining exceptional strength, flexibility, and aesthetic appeal.
Nanocellulose, a naturally occurring polymer, is eight times stronger than steel at a nanofibre level, making it an ideal foundation for high-performance textiles. Through advanced material science, Modern Synthesis has developed a scalable production method that preserves these remarkable properties while significantly reducing environmental impact.
Strategic Growth and Industry Adoption
The latest funding will drive Modern Synthesis’ expansion efforts, allowing the company to service more fashion brands eager to integrate sustainable textiles into their collections. The company has already demonstrated the potential of its biomaterials through a collaboration with Danish fashion brand GANNI. Together, they unveiled a prototype handbag and are now working towards a commercial launch of GANNI’s Bou Bag, featuring Modern Synthesis’ innovative material.
Despite growing demand for sustainable textiles, less than 5% of the $1 trillion global apparel textile market currently comprises eco-friendly alternatives. With over 35 new sustainability regulations expected to reshape the industry in the coming years, brands that fail to adapt may face significant financial risks, including up to 8% of EBIT losses, according to BCG analysis.
Industry Leaders Backing a Sustainable Vision
Jen Keane, CEO and Co-Founder of Modern Synthesis, highlighted the company’s mission: “We’ve proven that high-performance materials don’t have to rely on plastics. This investment enables us to scale our technology, helping fashion brands reduce their environmental footprint while delivering innovative, high-quality products.”
Yair Reem, Partner at Extantia Capital, expressed confidence in Modern Synthesis’ potential: “The material’s quality and versatility immediately stood out. This is not just a leather alternative, it’s an entirely new material that excites designers and redefines possibilities in sustainable fashion.”
Alexandra Clunies-Ross, Partner at Artesian Investments, added: “Modern Synthesis is driving a fundamental shift in manufacturing. Their technology presents a scalable solution that can significantly impact global supply chains and sustainability efforts.”
Expanding Beyond Fashion
With the support of leading climate-focused investors, Modern Synthesis is poised to reshape the fashion industry while paving the way for expansion into other sectors, including footwear and automotive applications. By bridging the gap between biotechnology and fashion, the company is setting a new standard for sustainable innovation.
